Wechselwirkungen von Acetazolamid

Acetazolamid (Diamox), ein Carboanhydrasehemmer, hat in den von uns erfassten FDA-Fachinformationen und Faktenblättern 348 dokumentierte Wechselwirkungen: 60 schwerwiegende, 255 mittelschwere, 30 geringfügige und 3, bei denen eine Fachinformation keine relevante Wechselwirkung berichtet. Jeder Eintrag unten zitiert den Satz, auf dem er beruht. Diese Medikamentenseite ist ein Ausgangspunkt, kein Urteil über Ihre persönliche Situation.

So sieht Acetazolamid aus

Alle 30 Varianten
Acetazolamid 125 mg Tablette: weiß, rund, 9 mm, mit Bruchkerbe, Prägung 1238.
1238
125 mg · weiß · rund · 9 mm · mit Bruchkerbe
Zydus Pharmaceuticals (USA)
Acetazolamid 250 mg Tablette: weiß, rund, 11 mm, Prägung 1239.
1239
250 mg · weiß · rund · 11 mm
Zydus Pharmaceuticals (USA)
Acetazolamid 500 mg Kapsel: orange, 24 mm, Prägung A auf der einen Seite und 247 auf der anderen.
A / 247
500 mg · orange · Kapsel · 24 mm
Alembic
Acetazolamid 500 mg Kapsel: gelb und weiß, 26 mm, Prägung XYL auf der einen Seite und 34 auf der anderen.
XYL / 34
500 mg · gelb und weiß · Kapsel · 26 mm
Zydus Pharmaceuticals (USA)

Darstellungen nach den Produktangaben der FDA-Fachinformationen: Farbe, Form, Größe und Prägung. 30 dokumentierte Varianten von 21 Anbietern.

Wechselwirkungen laut Fachinformation

Schwerwiegende Wechselwirkungen (60)

  • AcetylsalicylsäureNSARSchwerwiegend

    Caution is advised for patients receiving concomitant high-dose aspirin and acetazolamide, as anorexia, tachypnea, lethargy, metabolic acidosis, coma, and death have been reported. (Fachinformation zu Acetazolamid, Warnhinweise)

  • Acetylsalicylsäure und DipyridamolThrombozytenaggregationshemmerSchwerwiegend

    Caution is advised for patients receiving concomitant high-dose aspirin and acetazolamide, as anorexia, tachypnea, lethargy, metabolic acidosis, coma, and death have been reported. (Fachinformation zu Acetazolamid, Warnhinweise)

  • Alogliptin und MetforminDPP-4-HemmerSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Alogliptin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • ArsentrioxidQT-verlängerndes ArzneimittelSchwerwiegend

    The risk of torsade de pointes is related to the extent of QTc prolongation, concomitant administration of QTc prolonging drugs, a history of torsade de pointes, pre-existing QTc interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalemia or hypomagnesemia. (Fachinformation zu Arsentrioxid, Warnhinweise und Vorsichtsmaßnahmen)

  • Atenolol und ChlortalidonBetablockerSchwerwiegend

    CONTRAINDICATIONS Atenolol and chlorthalidone is contraindicated in patients with: sinus bradycardia; heart block greater than first degree; cardiogenic shock; overt cardiac failure (See WARNINGS ); anuria; hypersensitivity to this product or to sulfonamide-derived drugs. (Fachinformation zu Atenolol und Chlortalidon, Gegenanzeigen)

  • Benazepril und HydrochlorothiazidACE-HemmerSchwerwiegend

    Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs. (Fachinformation zu Benazepril und Hydrochlorothiazid, Gegenanzeigen)

  • Bisoprolol und HydrochlorothiazidBetablockerSchwerwiegend

    CONTRAINDICATIONS Bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see WARNINGS ), second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs. (Fachinformation zu Bisoprolol und Hydrochlorothiazid, Gegenanzeigen)

  • Caution is advised for patients receiving concomitant high-dose aspirin and acetazolamide, as anorexia, tachypnea, lethargy, metabolic acidosis, coma, and death have been reported. (Fachinformation zu Acetazolamid, Warnhinweise)

  • Caution is advised for patients receiving concomitant high-dose aspirin and acetazolamide, as anorexia, tachypnea, lethargy, metabolic acidosis, coma, and death have been reported. (Fachinformation zu Acetazolamid, Warnhinweise)

  • Candesartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Schwerwiegend

    CONTRAINDICATIONS Candesartan cilexetil and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to candesartan, to hydrochlorothiazide or to other sulfonamide-derived drugs. (Fachinformation zu Candesartan und Hydrochlorothiazid, Gegenanzeigen)

  • CelecoxibNSARSchwerwiegend

    • In patients who have demonstrated allergic-type reactions to sulfonamides [ see Warnings and Precautions (5.7) ]. (Fachinformation zu Celecoxib, Gegenanzeigen)

  • ChloroprocainLokalanästhetikumSchwerwiegend

    Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed. (Fachinformation zu Chloroprocain, Vorsichtsmaßnahmen)

  • ChlorothiazidThiaziddiuretikumSchwerwiegend

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (Fachinformation zu Chlorothiazid, Gegenanzeigen)

  • ChlortalidonThiaziddiuretikumSchwerwiegend

    THALITONE is contraindicated in patients with anuria or hypersensitivity to chlorthalidone or other sulfonamide-derived drugs. (Fachinformation zu Chlortalidon, Gegenanzeigen)

  • Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (Fachinformation zu Choriogonadotropin alfa, Warnhinweise)

  • CiclosporinImmunsuppressivumSchwerwiegend

    Potassium-Sparing Diuretics Cyclosporine should not be used with potassium-sparing diuretics because hyperkalemia can occur. (Fachinformation zu Ciclosporin, Arzneimittelwechselwirkungen)

  • CidofovirVirostatikumSchwerwiegend

    Cidofovir injection is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medications. (Fachinformation zu Cidofovir, Gegenanzeigen)

  • Dapagliflozin und MetforminSGLT-2-HemmerSchwerwiegend

    • Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Dapagliflozin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • DiclofenamidCarboanhydrasehemmerSchwerwiegend

    KEVEYIS is contraindicated in the following circumstances: Hypersensitivity to dichlorphenamide or other sulfonamides [see Warnings and Precautions (5.1) ] Concomitant use of KEVEYIS and high dose aspirin [see Warnings and Precautions (5.2) and Drug Interactions (7.1) ] Severe pulmonary disease, limiting compensation to metabolic acidosis caused by KEVEYIS [see… (Fachinformation zu Diclofenamid, Gegenanzeigen)

  • DofetilidAntiarrhythmikumSchwerwiegend

    In the DIAMOND trials, 1252 patients were treated with dofetilide and diuretics concomitantly, of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics. (Fachinformation zu Dofetilid, Arzneimittelwechselwirkungen)

  • DroperidolDopaminantagonistSchwerwiegend

    Droperidol should be administered with extreme caution to patients who may be at risk for development of prolonged QT syndrome (e.g., congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, hypomagnesemia, or administration of other drugs known to increase the QT interval). (Fachinformation zu Droperidol, Boxed Warning (umrahmter Warnhinweis))

  • Dutasterid und Tamsulosin5-Alpha-ReduktasehemmerSchwerwiegend

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin-containing products, including JALYN. (Fachinformation zu Dutasterid und Tamsulosin, Warnhinweise und Vorsichtsmaßnahmen)

  • Empagliflozin und MetforminSGLT-2-HemmerSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Empagliflozin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • Enalapril und HydrochlorothiazidACE-HemmerSchwerwiegend

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Enalapril und Hydrochlorothiazid, Gegenanzeigen)

  • EnalaprilatACE-HemmerSchwerwiegend

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (Fachinformation zu Enalaprilat, Warnhinweise)

  • EtacrynsäureSchleifendiuretikumSchwerwiegend

    Like other diuretics it may precipitate hepatic coma and death. (Fachinformation zu Etacrynsäure, Warnhinweise)

  • FollitropinSchwerwiegend

    Because the use of diuretics can accentuate the diminished intravascular volume, diuretics should be avoided except in the late phase of resolution as described below. (Fachinformation zu Follitropin, Warnhinweise und Vorsichtsmaßnahmen)

  • Fosinopril und HydrochlorothiazidACE-HemmerSchwerwiegend

    Fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any other ACE inhibitor, to hydrochlorothiazide, or other sulfonamide-derived drugs, or any other ingredient or component in the formulation. (Fachinformation zu Fosinopril und Hydrochlorothiazid, Gegenanzeigen)

  • GentamicinAminoglykosidSchwerwiegend

    The concurrent use of gentamicin with potent diuretics, such as ethacrynic acid or furosemide, should be avoided, since certain diuretics by themselves may cause ototoxicity. (Fachinformation zu Gentamicin, Boxed Warning (umrahmter Warnhinweis))

  • Glibenclamid und MetforminSulfonylharnstoffSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g. , acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Glibenclamid und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • GlimepiridSulfonylharnstoffSchwerwiegend

    • Sulfonamide derivatives: Patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets.Do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. (Fachinformation zu Glimepirid, Gegenanzeigen)

  • GlipizidSulfonylharnstoffSchwerwiegend

    • Hypersensitivity to sulfonamide derivatives. ▪ Known hypersensitivity to glipizide or any of the product's ingredients ( 4 ). ▪ Hypersensitivity to sulfonamide derivatives ( 4 ). (Fachinformation zu Glipizid, Gegenanzeigen)

  • HydrochlorothiazidThiaziddiuretikumSchwerwiegend

    In patients with hypersensitivity to sulfonamide-derived drugs. (Fachinformation zu Hydrochlorothiazid, Gegenanzeigen)

  • IndapamidThiaziddiuretikumSchwerwiegend

    Known hypersensitivity to indapamide or to other sulfonamide-derived drugs. (Fachinformation zu Indapamid, Gegenanzeigen)

  • Irbesartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Schwerwiegend

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Irbesartan und Hydrochlorothiazid, Gegenanzeigen)

  • IrinotecanSchwerwiegend

    Avoid diuretics or laxatives in patients with diarrhea. (Fachinformation zu Irinotecan, Warnhinweise und Vorsichtsmaßnahmen)

  • ItraconazolAzol-AntimykotikumSchwerwiegend

    Diuretics Eplerenone Contraindicated during and 2 weeks after TOLSURA treatment. (Fachinformation zu Itraconazol, Arzneimittelwechselwirkungen)

  • KaliumcitratKaliumpräparatSchwerwiegend

    The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: concomitant administration should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia (7.1) (Fachinformation zu Kaliumcitrat, Arzneimittelwechselwirkungen)

  • Linagliptin und MetforminDPP-4-HemmerSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Linagliptin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • Lisinopril und HydrochlorothiazidACE-HemmerSchwerwiegend

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Lisinopril und Hydrochlorothiazid, Gegenanzeigen)

  • MecamylaminAntihypertensivumSchwerwiegend

    Patients receiving antibiotics and sulfonamides should generally not be treated with ganglion blockers. (Fachinformation zu Mecamylamin, Gegenanzeigen)

  • MetforminBiguanidSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic… (Fachinformation zu Metformin, Boxed Warning (umrahmter Warnhinweis))

  • Metoprolol und HydrochlorothiazidBetablockerSchwerwiegend

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (Fachinformation zu Metoprolol und Hydrochlorothiazid, Gegenanzeigen)

  • MinoxidilVasodilatatorSchwerwiegend

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (Fachinformation zu Minoxidil, Boxed Warning (umrahmter Warnhinweis))

  • NatriumhydrogencarbonatAntazidumSchwerwiegend

    Sodium bicarbonate injection is contraindicated in patients who are losing chloride by vomiting or from continuous gastrointestinal suction and in patients receiving diuretics known to produce a hypochloremic alkalosis. (Fachinformation zu Natriumhydrogencarbonat, Gegenanzeigen)

  • NeomycinAminoglykosidSchwerwiegend

    The concurrent use of neomycin with potent diuretics such as ethacrynic acid or furosemide should be avoided, since certain diuretics by themselves may cause ototoxicity. (Fachinformation zu Neomycin, Boxed Warning (umrahmter Warnhinweis))

  • Olmesartan, Amlodipin und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Schwerwiegend

    Because of the hydrochlorothiazide component, olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet is contraindicated in patients with anuria, hypersensitivity to any component, or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Olmesartan, Amlodipin und Hydrochlorothiazid, Gegenanzeigen)

  • Caution is advised for patients receiving concomitant high-dose aspirin and acetazolamide, as anorexia, tachypnea, lethargy, metabolic acidosis, coma, and death have been reported. (Fachinformation zu Acetazolamid, Warnhinweise)

  • Phentermin und TopiramatZNS-StimulansSchwerwiegend

    Avoid use of phentermine and topiramate extended-release capsules with other carbonic anhydrase inhibitors. (Fachinformation zu Phentermin und Topiramat, Warnhinweise und Vorsichtsmaßnahmen)

  • Pioglitazon und GlimepiridThiazolidindion (Glitazon)Schwerwiegend

    Use in patients with known history of an allergic reaction to sulfonamide derivatives. (Fachinformation zu Pioglitazon und Glimepirid, Gegenanzeigen)

  • Pioglitazon und MetforminThiazolidindion (Glitazon)Schwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Pioglitazon und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • QuinaprilACE-HemmerSchwerwiegend

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (Fachinformation zu Quinapril, Warnhinweise)

  • Quinapril und HydrochlorothiazidACE-HemmerSchwerwiegend

    Because of the hydrochlorothiazide components, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Quinapril und Hydrochlorothiazid, Gegenanzeigen)

  • Saxagliptin und MetforminDPP-4-HemmerSchwerwiegend

    • Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure ), excessive alcohol intake, hepatic… (Fachinformation zu Saxagliptin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • Sitagliptin und MetforminDPP-4-HemmerSchwerwiegend

    Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (Fachinformation zu Sitagliptin und Metformin, Boxed Warning (umrahmter Warnhinweis))

  • Spironolacton und HydrochlorothiazidAldosteronantagonistSchwerwiegend

    CONTRAINDICATIONS Spironolactone and hydrochlorothiazide tablets are contraindicated in patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, hypercalcemia, hyperkalemia, Addison's disease, and in patients who are allergic to thiazide diuretics or to other sulfonamide-derived drugs. (Fachinformation zu Spironolacton und Hydrochlorothiazid, Gegenanzeigen)

  • TamsulosinAlphablockerSchwerwiegend

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (Fachinformation zu Tamsulosin, Warnhinweise und Vorsichtsmaßnahmen)

  • TopiramatAntiepileptikumSchwerwiegend

    Kidney stones: avoid use with other carbonic anhydrase inhibitors, drugs causing metabolic acidosis, or in patients on a ketogenic diet ( 5.13 ) (Fachinformation zu Topiramat, Warnhinweise und Vorsichtsmaßnahmen)

  • Triamteren und Hydrochlorothiazidkaliumsparendes DiuretikumSchwerwiegend

    Hypersensitivity Hypersensitivity to either drug in the preparation or to other sulfonamide-derived drugs is a contraindication. (Fachinformation zu Triamteren und Hydrochlorothiazid, Gegenanzeigen)

  • Valsartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Schwerwiegend

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (Fachinformation zu Valsartan und Hydrochlorothiazid, Gegenanzeigen)

Mittelschwere Wechselwirkungen (255)

  • AcarboseAntidiabetikumMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • AcebutololBetablockerMittelschwer

    Although β-blockers should be avoided in overt cardiac failure, acebutolol can be used with caution in patients with a history of heart failure who are controlled with digitalis and/or diuretics. (Fachinformation zu Acebutolol, Warnhinweise)

  • AdrenalinSympathomimetikumMittelschwer

    …Precautions (5.6) and Adverse Reactions (6) ]. β-blockers, such as propranolol Cyclopropane or halogenated hydrocarbon anesthetics, such as halothane Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics • Corticosteroids • Theophylline… (Fachinformation zu Adrenalin, Arzneimittelwechselwirkungen)

  • AliskirenAntihypertensivumMittelschwer

    Risk factors for the development of hyperkalemia include renal insufficiency, diabetes, combination use with ARBs or ACEIs [see Contraindications ( 4 ), Warnings and Precautions ( 5.2 ), and Clinical Studies ( 14.3 )] , NSAIDs, or potassium supplements or potassium sparing diuretics. (Fachinformation zu Aliskiren, Warnhinweise und Vorsichtsmaßnahmen)

  • AllopurinolXanthinoxidasehemmerMittelschwer

    Hypersensitivity reactions to allopurinol tablets may be increased in patients with decreased kidney function receiving thiazide diuretics and allopurinol tablets concurrently. (Fachinformation zu Allopurinol, Warnhinweise und Vorsichtsmaßnahmen)

  • AlmotriptanTriptanMittelschwer

    Use with caution in patients with a known hypersensitivity to sulfonamides ( 5.8 ) (Fachinformation zu Almotriptan, Warnhinweise und Vorsichtsmaßnahmen)

  • AlogliptinDPP-4-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • AmfepramonZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • AmfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Amfetamin und DexamfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • AmikacinAminoglykosidMittelschwer

    Ethacrynic Acid, Furosemide, Urea, or Mannitol Some diuretics can enhance aminoglycoside toxicity by altering aminoglycoside concentrations in serum and tissue. (Fachinformation zu Amikacin, Arzneimittelwechselwirkungen)

  • AmiodaronAntiarrhythmikumMittelschwer

    Give special attention to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or in patients receiving concomitant diuretics and laxatives. (Fachinformation zu Amiodaron, Warnhinweise und Vorsichtsmaßnahmen)

  • Amlodipin und BenazeprilDihydropyridin-CalciumkanalblockerMittelschwer

    Symptomatic hypotension is most likely to occur in patients who have heart failure, severe aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy or have been volume or salt depleted as a result of diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (Fachinformation zu Amlodipin und Benazepril, Warnhinweise und Vorsichtsmaßnahmen)

  • Amlodipin und OlmesartanDihydropyridin-CalciumkanalblockerMittelschwer

    In patients with an activated renin-angiotensin system, such as volume and/or salt-depleted patients (e.g., those being treated with high doses of diuretics) symptomatic hypotension may be anticipated after initiation of treatment with olmesartan medoxomil . (Fachinformation zu Amlodipin und Olmesartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Amlodipin und ValsartanDihydropyridin-CalciumkanalblockerMittelschwer

    In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur in patients receiving angiotensin receptor blockers. (Fachinformation zu Amlodipin und Valsartan, Warnhinweise und Vorsichtsmaßnahmen)

  • ArformoterolBeta-Adrenozeptor-AgonistMittelschwer

    Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (Fachinformation zu Arformoterol, Arzneimittelwechselwirkungen)

  • ArmodafinilZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Articain und AdrenalinLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine… (Fachinformation zu Articain und Adrenalin, Arzneimittelwechselwirkungen)

  • AzilsartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with azilsartan medoxomil. (Fachinformation zu Azilsartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Belladonna und OpiumOpioidMittelschwer

    Diuretics Clinical Impact : Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Belladonna und Opium, Arzneimittelwechselwirkungen)

  • BenazeprilACE-HemmerMittelschwer

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mm Hg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (Fachinformation zu Benazepril, Warnhinweise und Vorsichtsmaßnahmen)

  • BenzfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • BexagliflozinSGLT-2-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • BrinzolamidCarboanhydrasehemmerMittelschwer

    Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • BrivaracetamAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • BromocriptinDopaminagonistMittelschwer

    Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (Fachinformation zu Bromocriptin, Arzneimittelwechselwirkungen)

  • Budesonid und FormoterolKortikosteroidMittelschwer

    Diuretics: Use with caution. (Fachinformation zu Budesonid und Formoterol, Arzneimittelwechselwirkungen)

  • BumetanidSchleifendiuretikumMittelschwer

    Like other members of this class of diuretics, bumetanide probably shares this risk. (Fachinformation zu Bumetanid, Warnhinweise)

  • Bupivacain und AdrenalinLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent… (Fachinformation zu Bupivacain und Adrenalin, Arzneimittelwechselwirkungen)

  • BuprenorphinOpioidMittelschwer

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Buprenorphin, Arzneimittelwechselwirkungen)

  • Buprenorphin und NaloxonOpioidMittelschwer

    Examples: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Buprenorphin und Naloxon, Arzneimittelwechselwirkungen)

  • Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • CalciumchloridMittelschwer

    Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (Fachinformation zu Calciumchlorid, Arzneimittelwechselwirkungen)

  • CanagliflozinSGLT-2-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • CandesartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (Fachinformation zu Candesartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Cannabidiol (verschreibungspflichtig)AntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • CaptoprilACE-HemmerMittelschwer

    Hypotension Excessive hypotension was rarely seen in hypertensive patients but is a possible consequence of captopril use in salt/volume depleted persons (such as those treated vigorously with diuretics), patients with heart failure or those patients undergoing renal dialysis (see PRECAUTIONS : Drug Interactions ). (Fachinformation zu Captopril, Warnhinweise)

  • CarbamazepinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • CarvedilolBetablockerMittelschwer

    If such symptoms occur, diuretics should be increased and the carvedilol dose should not be advanced until clinical stability resumes [see Dosage and Administration (2) ] . (Fachinformation zu Carvedilol, Warnhinweise und Vorsichtsmaßnahmen)

  • CefepimCephalosporinMittelschwer

    Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (Fachinformation zu Cefepim, Arzneimittelwechselwirkungen)

  • CeftazidimCephalosporinMittelschwer

    Drug Interactions Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibacterial drugs or potent diuretics such as furosemide. (Fachinformation zu Ceftazidim, Arzneimittelwechselwirkungen)

  • CenobamatAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ChinidinAntiarrhythmikumMittelschwer

    Acetazolamide reduces urinary excretion of quinidine and may enhance its effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ChininMalariamittelMittelschwer

    Urinary Alkalizers (Acetazolamide, Sodium Bicarbonate) Urinary alkalinizing agents may increase plasma quinine concentrations. (Fachinformation zu Chinin, Arzneimittelwechselwirkungen)

  • ChlorpromazinAntipsychotikumMittelschwer

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (Fachinformation zu Chlorpromazin, Vorsichtsmaßnahmen)

  • CitalopramSSRIMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume depleted may be at greater risk for developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Citalopram, Warnhinweise und Vorsichtsmaßnahmen)

  • ClobazamBenzodiazepinMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ClofarabinAntimetabolitMittelschwer

    Consider use of diuretics and/or albumin. (Fachinformation zu Clofarabin, Warnhinweise und Vorsichtsmaßnahmen)

  • ClonazepamBenzodiazepinMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ClozapinAntipsychotikumMittelschwer

    Hypokalemia can result from diuretic therapy, diarrhea, and other causes. (Fachinformation zu Clozapin, Warnhinweise und Vorsichtsmaßnahmen)

  • CodeinOpioidMittelschwer

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Codein, Arzneimittelwechselwirkungen)

  • ColestyraminGallensäurebinderMittelschwer

    Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (Fachinformation zu Colestyramin, Arzneimittelwechselwirkungen)

  • CyclophosphamidImmunsuppressivumMittelschwer

    …inhibitors can cause leukopenia. ● Natalizumab ● Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion. ● Thiazide diuretics ● Zidovudine Increased cardiotoxicity ● Anthracyclines ● Cytarabine ● Pentostatin ● Radiation therapy of the cardiac region ● Trastuzumab Increased pulmonary toxicity ● Amiodarone… (Fachinformation zu Cyclophosphamid, Arzneimittelwechselwirkungen)

  • DapagliflozinSGLT-2-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Darunavirantiretrovirales ArzneimittelMittelschwer

    Use with caution in patients with a known sulfonamide allergy. (Fachinformation zu Darunavir, Warnhinweise und Vorsichtsmaßnahmen)

  • Darunavir und Cobicistatantiretrovirales ArzneimittelMittelschwer

    Monitor in patients with a known sulfonamide allergy. (Fachinformation zu Darunavir und Cobicistat, Warnhinweise und Vorsichtsmaßnahmen)

  • Desipramintrizyklisches AntidepressivumMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with NORPRAMIN. (Fachinformation zu Desipramin, Warnhinweise)

  • DesmopressinMittelschwer

    …Hyponatremia Concomitant administration of DESMODA with other drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, thiazide diuretics, NSAIDs, lamotrigine, sulfonylureas, particularly chlorpropamide, oxybutynin and carbamazepine). (Fachinformation zu Desmopressin, Arzneimittelwechselwirkungen)

  • DesvenlafaxinSNRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk [see Use in Specific Populations (8.5) and Clinical Pharmacology (12.3) ] . (Fachinformation zu Desvenlafaxin, Warnhinweise und Vorsichtsmaßnahmen)

  • DexamfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • DexlansoprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (Fachinformation zu Dexlansoprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • DexmethylphenidatZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Dextromethorphan und Chinidinserotonerges ArzneimittelMittelschwer

    Acetazolamide reduces urinary excretion of quinidine and may enhance its effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • DiazoxidMittelschwer

    The concomitant administration of thiazides or other diuretics may potentiate the hyperglycemic and hyperuricemic effects of PROGLYCEM. (Fachinformation zu Diazoxid, Arzneimittelwechselwirkungen)

  • DiclofenacNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Diclofenac, Warnhinweise und Vorsichtsmaßnahmen)

  • Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Diclofenac und Misoprostol, Warnhinweise und Vorsichtsmaßnahmen)

  • DiflunisalNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, patients who are volume depleted, and the elderly. (Fachinformation zu Diflunisal, Warnhinweise)

  • DigoxinDigitalisglykosidMittelschwer

    Serum potassium levels should be carefully monitored when digoxin is given to patients at high risk of hypokalemia ( e.g. , those receiving diuretics, corticosteroids, or other drugs that commonly lead to potassium loss; those with gastrointestinal losses through diarrhea, vomiting, or nasogastric suction; or those with potassium-losing endocrinopathies or nephropathies). (Fachinformation zu Digoxin, Warnhinweise und Vorsichtsmaßnahmen)

  • DorzolamidCarboanhydrasehemmerMittelschwer

    Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Dorzolamid und TimololCarboanhydrasehemmerMittelschwer

    Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • DoxercalciferolVitamin-D-AnalogonMittelschwer

    Risk may be increased when used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (Fachinformation zu Doxercalciferol, Warnhinweise und Vorsichtsmaßnahmen)

  • Drospirenon und Ethinylestradiolorales KontrazeptivumMittelschwer

    Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS. (Fachinformation zu Drospirenon und Ethinylestradiol, Warnhinweise und Vorsichtsmaßnahmen)

  • DulaglutidGLP-1-RezeptoragonistMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • DuloxetinSNRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Duloxetin, Warnhinweise und Vorsichtsmaßnahmen)

  • EmpagliflozinSGLT-2-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • EnalaprilACE-HemmerMittelschwer

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (Fachinformation zu Enalapril, Warnhinweise und Vorsichtsmaßnahmen)

  • EpoprostenolProstaglandin-AnalogonMittelschwer

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (Fachinformation zu Epoprostenol, Arzneimittelwechselwirkungen)

  • Ergotamin und KoffeinMutterkornalkaloidMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • EscitalopramSSRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (Fachinformation zu Escitalopram, Warnhinweise und Vorsichtsmaßnahmen)

  • EslicarbazepinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • EsomeprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (Fachinformation zu Esomeprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • EthosuximidAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • EtodolacNSARMittelschwer

    Patients at greater risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, and the elderly. (Fachinformation zu Etodolac, Warnhinweise)

  • ExenatidGLP-1-RezeptoragonistMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • FelbamatAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • FenoprofenNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Fenoprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • FentanylOpioidMittelschwer

    …treatment with Class 1 and Class III antiarrhythmics, 4) treatment with monoamine oxidase inhibitors (MAOI's), 5) concomitant treatment with other drug products known to prolong the QT interval and 6) electrolyte imbalance, in particular hypokalemia and hypomagnesemia, or concomitant treatment with drugs (e.g., diuretics) that may cause electrolyte imbalance. (Fachinformation zu Fentanyl, Warnhinweise und Vorsichtsmaßnahmen)

  • FluconazolAzol-AntimykotikumMittelschwer

    An effect of this magnitude should not necessitate a change in the fluconazole dose regimen in subjects receiving concomitant diuretics. (Fachinformation zu Fluconazol, Arzneimittelwechselwirkungen)

  • FludrocortisonKortikosteroidMittelschwer

    Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (Fachinformation zu Fludrocortison, Arzneimittelwechselwirkungen)

  • FluoxetinSSRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Fluoxetin, Warnhinweise und Vorsichtsmaßnahmen)

  • FlurbiprofenNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Flurbiprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • Fluticason und SalmeterolKortikosteroidMittelschwer

    Diuretics: Use with caution. (Fachinformation zu Fluticason und Salmeterol, Arzneimittelwechselwirkungen)

  • FluvoxaminSSRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (Fachinformation zu Fluvoxamin, Warnhinweise und Vorsichtsmaßnahmen)

  • Folsäure (Folat)Vitamine und MineralstoffeMittelschwer

    Acetazolamide may increase the effects of other folic acid antagonists. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • FormoterolBeta-Adrenozeptor-AgonistMittelschwer

    • Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (Fachinformation zu Formoterol, Arzneimittelwechselwirkungen)

  • Fosamprenavirantiretrovirales ArzneimittelMittelschwer

    Fosamprenavir calcium should be used with caution in patients with a known sulfonamide allergy. (Fachinformation zu Fosamprenavir, Warnhinweise und Vorsichtsmaßnahmen)

  • FoscarnetVirostatikumMittelschwer

    When diuretics are indicated, thiazides are recommended over loop diuretics because the latter inhibit renal tubular secretion, and may impair elimination of FOSCAVIR, potentially leading to toxicity. (Fachinformation zu Foscarnet, Arzneimittelwechselwirkungen)

  • FosinoprilACE-HemmerMittelschwer

    Symptomatic hypotension is most likely to occur in patients who have been volume- and/or salt-depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (Fachinformation zu Fosinopril, Warnhinweise)

  • FosphenytoinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • GabapentinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • GlibenclamidSulfonylharnstoffMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Glipizid und MetforminSulfonylharnstoffMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • HaloperidolAntipsychotikumMittelschwer

    Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (Fachinformation zu Haloperidol, Arzneimittelwechselwirkungen)

  • Humaninsulin (Normalinsulin)InsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • HydrocodonOpioidMittelschwer

    Example: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Hydrocodon, Arzneimittelwechselwirkungen)

  • Diuretics : Hydrocodone may reduce the efficacy of diuretics. (Fachinformation zu Hydrocodon und Chlorphenamin, Arzneimittelwechselwirkungen)

  • Hydrocodon und HomatropinOpioidMittelschwer

    Diuretics : Hydrocodone may reduce the efficacy of diuretics. (Fachinformation zu Hydrocodon und Homatropin, Arzneimittelwechselwirkungen)

  • Hydrocodon und IbuprofenOpioidMittelschwer

    Patients taking angiotensin converting enzyme (ACE) inhibitors, thiazide diuretics, or loop diuretics may have impaired response to these therapies when taking NSAIDs (see PRECAUTIONS: Drug Interactions). (Fachinformation zu Hydrocodon und Ibuprofen, Warnhinweise)

  • Hydrocodon und ParacetamolOpioidMittelschwer

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Hydrocodon und Paracetamol, Arzneimittelwechselwirkungen)

  • HydromorphonOpioidMittelschwer

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Hydromorphon, Arzneimittelwechselwirkungen)

  • IbuprofenNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Ibuprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • Ibuprofen und FamotidinNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE-inhibitors or ARBs, and the elderly. (Fachinformation zu Ibuprofen und Famotidin, Warnhinweise und Vorsichtsmaßnahmen)

  • Imipramintrizyklisches AntidepressivumMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with imipramine hydrochloride tablets. (Fachinformation zu Imipramin, Warnhinweise)

  • IndometacinNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Indometacin, Warnhinweise und Vorsichtsmaßnahmen)

  • Insulin aspartInsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Insulin degludecInsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Insulin detemirInsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Insulin glarginInsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Insulin lisproInsulinMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Ipratropiumbromid und SalbutamolAnticholinergikumMittelschwer

    Diuretics The electrocardiogram (ECG) changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by β-agonists, especially when the recommended dose of the β-agonist is exceeded. (Fachinformation zu Ipratropiumbromid und Salbutamol, Arzneimittelwechselwirkungen)

  • IrbesartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension in Volume or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initialization of treatment with AVAPRO. (Fachinformation zu Irbesartan, Warnhinweise und Vorsichtsmaßnahmen)

  • KaliumiodidMittelschwer

    Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest. (Fachinformation zu Kaliumiodid, Arzneimittelwechselwirkungen)

  • KetoconazolAzol-AntimykotikumMittelschwer

    Diuretics eplerenone The potential increase in plasma concentrations of eplerenone when coadministered with ketoconazole tablets may increase the risk of hyperkalemia and hypotension. (Fachinformation zu Ketoconazol, Arzneimittelwechselwirkungen)

  • KetoprofenNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics, and the elderly. (Fachinformation zu Ketoprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • KetorolacNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, and the elderly. (Fachinformation zu Ketorolac, Warnhinweise und Vorsichtsmaßnahmen)

  • LacosamidAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LamotriginAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LansoprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (Fachinformation zu Lansoprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • LevetiracetamAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LevomilnacipranSNRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk. (Fachinformation zu Levomilnacipran, Warnhinweise und Vorsichtsmaßnahmen)

  • LevorphanolOpioidMittelschwer

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Levorphanol, Arzneimittelwechselwirkungen)

  • LevosalbutamolBeta-Adrenozeptor-AgonistMittelschwer

    Diuretics The ECG changes or hypokalemia that may result from the administration of non-potassium-sparing diuretics (such as loop and thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (Fachinformation zu Levosalbutamol, Arzneimittelwechselwirkungen)

  • Lidocain und AdrenalinLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent… (Fachinformation zu Lidocain und Adrenalin, Arzneimittelwechselwirkungen)

  • LinagliptinDPP-4-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LinezolidAntibiotikumMittelschwer

    Monitor serum sodium levels regularly in the elderly, in patients taking diuretics, and in other patients at risk of hyponatremia and/or SIADH while taking Linezolid injection. (Fachinformation zu Linezolid, Warnhinweise und Vorsichtsmaßnahmen)

  • LiraglutidGLP-1-RezeptoragonistMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LisdexamfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LisinoprilACE-HemmerMittelschwer

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (Fachinformation zu Lisinopril, Warnhinweise und Vorsichtsmaßnahmen)

  • Lithiumserotonerges ArzneimittelMittelschwer

    Acetazolamide increases lithium excretion and the lithium may be decreased. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • LosartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with COZAAR. (Fachinformation zu Losartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Losartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Fachinformation zu Losartan und Hydrochlorothiazid, Warnhinweise und Vorsichtsmaßnahmen)

  • MefenaminsäureNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Mefenaminsäure, Warnhinweise und Vorsichtsmaßnahmen)

  • MeloxicamNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Meloxicam, Warnhinweise und Vorsichtsmaßnahmen)

  • MepivacainLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (Fachinformation zu Mepivacain, Arzneimittelwechselwirkungen)

  • MesuximidAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MetamfetaminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MethadonOpioidMittelschwer

    Closely monitor patients with risk factors for development of prolonged QT interval (e.g., cardiac hypertrophy, concomitant diuretic use, hypokalemia, hypomagnesemia), a history of cardiac conduction abnormalities, and those taking medications affecting cardiac conduction. (Fachinformation zu Methadon, Warnhinweise und Vorsichtsmaßnahmen)

  • MethazolamidCarboanhydrasehemmerMittelschwer

    Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MethylphenidatZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MetolazonThiaziddiuretikumMittelschwer

    Anticoagulants Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; dosage adjustments may be necessary. (Fachinformation zu Metolazon, Arzneimittelwechselwirkungen)

  • MetoprololBetablockerMittelschwer

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of Metoprolol Tartrate Tablets [see Dosage and Administration (2) ]. (Fachinformation zu Metoprolol, Warnhinweise und Vorsichtsmaßnahmen)

  • MiglitolAntidiabetikumMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MilnacipranSNRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Geriatric Use ( 8.5 )] . (Fachinformation zu Milnacipran, Warnhinweise und Vorsichtsmaßnahmen)

  • MirtazapinAntidepressivumMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia [see Use in Specific Populations (8.5) ] . (Fachinformation zu Mirtazapin, Warnhinweise und Vorsichtsmaßnahmen)

  • ModafinilZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MoexiprilACE-HemmerMittelschwer

    Symptomatic hypotension is most likely to occur in patients who have been salt- and volume- depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (Fachinformation zu Moexipril, Warnhinweise)

  • MorphinOpioidMittelschwer

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Morphin, Arzneimittelwechselwirkungen)

  • NabumetonNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics, and the elderly. (Fachinformation zu Nabumeton, Warnhinweise)

  • NadololBetablockerMittelschwer

    Although beta-blockers should be avoided in overt congestive heart failure, if necessary, they can be used with caution in patients with a history of failure who are well-compensated, usually with digitalis and diuretics. (Fachinformation zu Nadolol, Warnhinweise)

  • NalbuphinOpioidMittelschwer

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Nalbuphin, Arzneimittelwechselwirkungen)

  • NaproxenNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Naproxen, Warnhinweise und Vorsichtsmaßnahmen)

  • Naproxen und EsomeprazolNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE-inhibitors or ARBs, and the elderly. (Fachinformation zu Naproxen und Esomeprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • NateglinidGlinidMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Increase the dose of diuretics as needed [see Adverse Reactions (6) ] . (Fachinformation zu Natrium-Zirconium-Cyclosilicat, Warnhinweise und Vorsichtsmaßnahmen)

  • NifedipinDihydropyridin-CalciumkanalblockerMittelschwer

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (Fachinformation zu Nifedipin, Arzneimittelwechselwirkungen)

  • NimodipinDihydropyridin-CalciumkanalblockerMittelschwer

    Blood Pressure Lowering Drugs Nimodipine may increase the blood pressure lowering effect of concomitantly administered anti-hypertensives such as diuretics, beta-blockers, ACE inhibitors, angiotensin receptor blockers, other calcium channel blockers, α-adrenergic blockers, PDE5 inhibitors, and α-methyldopa. (Fachinformation zu Nimodipin, Arzneimittelwechselwirkungen)

  • Olanzapin und FluoxetinAntipsychotikumMittelschwer

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (Fachinformation zu Olanzapin und Fluoxetin, Warnhinweise und Vorsichtsmaßnahmen)

  • OliceridinOpioidMittelschwer

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Oliceridin, Arzneimittelwechselwirkungen)

  • OlmesartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin-aldosterone system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with Benicar. (Fachinformation zu Olmesartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Olmesartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Fachinformation zu Olmesartan und Hydrochlorothiazid, Warnhinweise und Vorsichtsmaßnahmen)

  • OmeprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (Fachinformation zu Omeprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • Omeprazol und NatriumhydrogencarbonatProtonenpumpenhemmer (PPI)Mittelschwer

    Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • OxaprozinNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Oxaprozin, Warnhinweise und Vorsichtsmaßnahmen)

  • OxcarbazepinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • OxycodonOpioidMittelschwer

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Oxycodon, Arzneimittelwechselwirkungen)

  • Oxycodon und ParacetamolOpioidMittelschwer

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Oxycodon und Paracetamol, Arzneimittelwechselwirkungen)

  • OxymorphonOpioidMittelschwer

    Examples: butorphanol, nalbuphine, pentazocine, buprenorphine Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Oxymorphon, Arzneimittelwechselwirkungen)

  • PantoprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (Fachinformation zu Pantoprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • Paracetamol und CodeinOpioidMittelschwer

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Paracetamol und Codein, Arzneimittelwechselwirkungen)

  • Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Paracetamol und Ibuprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • ParicalcitolVitamin-D-AnalogonMittelschwer

    The risk may be increased when Paricalcitol Injection is used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (Fachinformation zu Paricalcitol, Warnhinweise und Vorsichtsmaßnahmen)

  • ParoxetinSSRIMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SNRIs and SSRIs. [see Use in Specific Populations ( 8.5 )]. (Fachinformation zu Paroxetin, Warnhinweise und Vorsichtsmaßnahmen)

  • Pentazocin und NaloxonOpioidMittelschwer

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Pentazocin und Naloxon, Arzneimittelwechselwirkungen)

  • PerampanelAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PerindoprilACE-HemmerMittelschwer

    Symptomatic hypotension is most likely to occur in patients who have been volume or salt-depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea or vomiting [see Dosage and Administration (2.1) ] . (Fachinformation zu Perindopril, Warnhinweise und Vorsichtsmaßnahmen)

  • PethidinOpioidMittelschwer

    Examples: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Pethidin, Arzneimittelwechselwirkungen)

  • PhendimetrazinZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PhenelzinMAO-HemmerMittelschwer

    …hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (Fachinformation zu Phenelzin, Warnhinweise)

  • PhenobarbitalBarbituratMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PhenterminZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PhenytoinAntiepileptikumMittelschwer

    Acetazolamide modifies phenytoin metabolism with increased serum levels of phenytoin. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PindololBetablockerMittelschwer

    Although beta-blockers should be avoided in overt congestive heart failure, if necessary, pindolol tablets can be used with caution in patients with a history of failure who are well-compensated, usually with digitalis and diuretics. (Fachinformation zu Pindolol, Warnhinweise)

  • PioglitazonThiazolidindion (Glitazon)Mittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • PiroxicamNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors or ARBs, and the elderly. (Fachinformation zu Piroxicam, Warnhinweise und Vorsichtsmaßnahmen)

  • PrazosinAlphablockerMittelschwer

    Addition of a diuretic or other antihypertensive agent to prazosin hydrochloride capsules has been shown to cause an additive hypotensive effect. (Fachinformation zu Prazosin, Arzneimittelwechselwirkungen)

  • PregabalinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Prilocain und AdrenalinLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine The administration… (Fachinformation zu Prilocain und Adrenalin, Arzneimittelwechselwirkungen)

  • PrimidonAntiepileptikumMittelschwer

    Caution is advised when beginning, discontinuing, or changing the dose of acetazolamide in patients receiving primidone. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ProbenecidMittelschwer

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (Fachinformation zu Probenecid, Arzneimittelwechselwirkungen)

  • Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (Fachinformation zu Probenecid und Colchicin, Arzneimittelwechselwirkungen)

  • ProchlorperazinAntipsychotikumMittelschwer

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (Fachinformation zu Prochlorperazin, Vorsichtsmaßnahmen)

  • Promethazin und CodeinOpioidMittelschwer

    Diuretics : Codeine may reduce the efficacy of diuretics. (Fachinformation zu Promethazin und Codein, Arzneimittelwechselwirkungen)

  • PyrimethaminMalariamittelMittelschwer

    However, the concomitant use of other antifolic drugs or agents associated with myelosuppression including sulfonamides or trimethoprim- sulfamethoxazole combinations, proguanil, zidovudine, or cytostatic agents (e.g., methotrexate), while the patient is receiving pyrimethamine, may increase the risk of bone marrow suppression. (Fachinformation zu Pyrimethamin, Arzneimittelwechselwirkungen)

  • RabeprazolProtonenpumpenhemmer (PPI)Mittelschwer

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (Fachinformation zu Rabeprazol, Warnhinweise und Vorsichtsmaßnahmen)

  • RamiprilACE-HemmerMittelschwer

    Experience with another ACE inhibitor suggests that these increases would be reversible upon discontinuation of ramipril and/or diuretic therapy. (Fachinformation zu Ramipril, Warnhinweise und Vorsichtsmaßnahmen)

  • RepaglinidGlinidMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • RopivacainLokalanästhetikumMittelschwer

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine NAROPIN… (Fachinformation zu Ropivacain, Arzneimittelwechselwirkungen)

  • RufinamidAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • Sacubitril und ValsartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), are at greater risk. (Fachinformation zu Sacubitril und Valsartan, Warnhinweise und Vorsichtsmaßnahmen)

  • SalbutamolBeta-Adrenozeptor-AgonistMittelschwer

    Diuretics: Use with caution. (Fachinformation zu Salbutamol, Arzneimittelwechselwirkungen)

  • SalmeterolBeta-Adrenozeptor-AgonistMittelschwer

    • Diuretics: Use with caution. (Fachinformation zu Salmeterol, Arzneimittelwechselwirkungen)

  • SalsalatNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, and the elderly. (Fachinformation zu Salsalat, Warnhinweise)

  • SaxagliptinDPP-4-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • SemaglutidGLP-1-RezeptoragonistMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • SertralinSSRIMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Sertralin, Warnhinweise und Vorsichtsmaßnahmen)

  • SitagliptinDPP-4-HemmerMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • SolriamfetolZNS-StimulansMittelschwer

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • SotalolBetablockerMittelschwer

    Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs. (Fachinformation zu Sotalol, Warnhinweise und Vorsichtsmaßnahmen)

  • SpironolactonAldosteronantagonistMittelschwer

    …drugs that can increase potassium include: ACE inhibitors angiotensin receptor blockers aldosterone blockers non-steroidal anti-inflammatory drugs (NSAIDs) heparin and low molecular weight heparin trimethoprim 7.2 Lithium Like other diuretics, spironolactone oral suspension reduces the renal clearance of lithium, thus increasing the risk of lithium toxicity. (Fachinformation zu Spironolacton, Arzneimittelwechselwirkungen)

  • Drug Interactions In elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombocytopenia with purpura has been reported. (Fachinformation zu Sulfamethoxazol und Trimethoprim (Cotrimoxazol), Arzneimittelwechselwirkungen)

  • SulindacNSARMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, patients who are volume-depleted, and the elderly. (Fachinformation zu Sulindac, Warnhinweise)

  • Sumatriptan und NaproxenTriptanMittelschwer

    Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, salt depletion, those taking diuretics and angiotensin-converting enzyme (ACE) inhibitors or ARBs, and the elderly. (Fachinformation zu Sumatriptan und Naproxen, Warnhinweise und Vorsichtsmaßnahmen)

  • Suxamethoniumneuromuskulärer BlockerMittelschwer

    Prolonged Neuromuscular Block in Patients with Hypokalemia or Hypocalcemia Neuromuscular blockade may be prolonged in patients with hypokalemia (e.g., after severe vomiting, diarrhea, digitalisation and diuretic therapy) or hypocalcemia (e.g., after massive transfusions). (Fachinformation zu Suxamethonium, Warnhinweise und Vorsichtsmaßnahmen)

  • TacrolimusImmunsuppressivumMittelschwer

    Concomitant use of agents associated with hyperkalemia (e.g., potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers) may increase the risk for hyperkalemia [see Adverse Reactions ( 6.1 )] . (Fachinformation zu Tacrolimus, Warnhinweise und Vorsichtsmaßnahmen)

  • TapentadolOpioidMittelschwer

    …use of skeletal muscle relaxants and opioids, consider prescribing naloxone for the emergency treatment of opioid overdose [see Dosage and Administration (2.2) , Warnings and Precautions (5.2 , 5.3) ] Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Tapentadol, Arzneimittelwechselwirkungen)

  • TelmisartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with telmisartan tablets. (Fachinformation zu Telmisartan, Warnhinweise und Vorsichtsmaßnahmen)

  • Telmisartan und AmlodipinAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Hypotension Telmisartan In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with telmisartan and amlodipine tablets. (Fachinformation zu Telmisartan und Amlodipin, Warnhinweise und Vorsichtsmaßnahmen)

  • Telmisartan und HydrochlorothiazidAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Fachinformation zu Telmisartan und Hydrochlorothiazid, Warnhinweise und Vorsichtsmaßnahmen)

  • TerbutalinBeta-Adrenozeptor-AgonistMittelschwer

    Diuretics The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (Fachinformation zu Terbutalin, Vorsichtsmaßnahmen)

  • TiagabinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • TirzepatidGLP-1-RezeptoragonistMittelschwer

    Consideration should be taken in patients being treated with antidiabetic agents. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • TobramycinAminoglykosidMittelschwer

    Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. (Fachinformation zu Tobramycin, Arzneimittelwechselwirkungen)

  • TolmetinNSARMittelschwer

    Use of tolmetin may blunt the CV effects of several therapeutic agents used to treat these medical conditions [e.g., diuretics, ACE inhibitors, or angiotensin receptor blockers (ARBs)] (see PRECAUTIONS: Drug Interactions ). (Fachinformation zu Tolmetin, Warnhinweise)

  • TolvaptanMittelschwer

    Co-administration of diuretics also increases the risk of too rapid correction of serum sodium and such patients should undergo close monitoring of serum sodium. (Fachinformation zu Tolvaptan, Warnhinweise und Vorsichtsmaßnahmen)

  • TorasemidSchleifendiuretikumMittelschwer

    Lithium Like other diuretics, torsemide reduces the renal clearance of lithium, inducing a high risk of lithium toxicity. (Fachinformation zu Torasemid, Arzneimittelwechselwirkungen)

  • Toremifenselektiver Estrogenrezeptormodulator (SERM)Mittelschwer

    Drugs that decrease renal calcium excretion, e.g., thiazide diuretics, may increase the risk of hypercalcemia in patients receiving FARESTON. (Fachinformation zu Toremifen, Arzneimittelwechselwirkungen)

  • TramadolOpioidMittelschwer

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Tramadol, Arzneimittelwechselwirkungen)

  • Tramadol und ParacetamolOpioidMittelschwer

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (Fachinformation zu Tramadol und Paracetamol, Arzneimittelwechselwirkungen)

  • TrandolaprilACE-HemmerMittelschwer

    Symptomatic hypotension is most likely to occur in patients who have been salt- or volume-depleted as a result of prolonged treatment with diuretics, dietary salt restriction, dialysis, diarrhea, or vomiting. (Fachinformation zu Trandolapril, Warnhinweise)

  • TrazodonAntidepressivumMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs [see Use in Specific Populations (8.5) ] . (Fachinformation zu Trazodon, Warnhinweise und Vorsichtsmaßnahmen)

  • Triamterenkaliumsparendes DiuretikumMittelschwer

    The effects of the following drugs may be potentiated when given together with triamterene: antihypertensive medication, other diuretics, preanesthetic and anesthetic agents, skeletal muscle relaxants (non-depolarizing). (Fachinformation zu Triamteren, Arzneimittelwechselwirkungen)

  • TrifluoperazinAntipsychotikumMittelschwer

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (Fachinformation zu Trifluoperazin, Vorsichtsmaßnahmen)

  • Umeclidiniumbromid und VilanterolAnticholinergikumMittelschwer

    • Diuretics: Use with caution. (Fachinformation zu Umeclidiniumbromid und Vilanterol, Arzneimittelwechselwirkungen)

  • Valproat-Seminatrium (Divalproex)AntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ValproinsäureAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • ValsartanAngiotensin-II-Rezeptorblocker (Sartan)Mittelschwer

    In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. (Fachinformation zu Valsartan, Warnhinweise und Vorsichtsmaßnahmen)

  • VenlafaxinSNRIMittelschwer

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Venlafaxin, Warnhinweise und Vorsichtsmaßnahmen)

  • VerapamilCalciumkanalblockerMittelschwer

    Control patients with milder ventricular dysfunction, if possible, with optimum doses of digitalis and/or diuretics before verapamil treatment is started [see Drug Interactions ( 7.5 )] . (Fachinformation zu Verapamil, Warnhinweise und Vorsichtsmaßnahmen)

  • VigabatrinAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • VilazodonSSRIMittelschwer

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs [see Use in Specific Populations ( 8.5 )] . (Fachinformation zu Vilazodon, Warnhinweise und Vorsichtsmaßnahmen)

  • VortioxetinAntidepressivumMittelschwer

    Also, patients taking diuretics or who are otherwise volume-depleted can be at greater risk. (Fachinformation zu Vortioxetin, Warnhinweise und Vorsichtsmaßnahmen)

  • ZiprasidonAntipsychotikumMittelschwer

    Hypokalemia may result from diuretic therapy, diarrhea, and other causes. (Fachinformation zu Ziprasidon, Warnhinweise und Vorsichtsmaßnahmen)

  • ZoledronsäureBisphosphonatMittelschwer

    Elderly patients and those receiving diuretic therapy are at increased risk of acute renal failure. (Fachinformation zu Zoledronsäure, Warnhinweise und Vorsichtsmaßnahmen)

  • ZonisamidAntiepileptikumMittelschwer

    By decreasing the gastrointestinal absorption of primidone, acetazolamide may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

Geringfügige Erwähnungen (30)

  • AmbrisentanGeringfügig

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (Fachinformation zu Ambrisentan, Warnhinweise und Vorsichtsmaßnahmen)

  • AmoxicillinPenicillin-AntibiotikumGeringfügig

    Other Antibacterials Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. (Fachinformation zu Amoxicillin, Arzneimittelwechselwirkungen)

  • AmpicillinPenicillin-AntibiotikumGeringfügig

    Bacteriostatic Antibiotics : Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins. (Fachinformation zu Ampicillin, Arzneimittelwechselwirkungen)

  • Benzylpenicillin (Penicillin G)Penicillin-AntibiotikumGeringfügig

    Drug Interactions Bacteriostatic antibacterials ( i.e. , chloramphenicol, erythromycins, sulfonamides or tetracyclines) may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. (Fachinformation zu Benzylpenicillin (Penicillin G), Arzneimittelwechselwirkungen)

  • BetaxololBetablockerGeringfügig

    In hypertensive patients who have congestive heart failure controlled by digitalis and diuretics, beta-blockers should be administered cautiously. (Fachinformation zu Betaxolol, Warnhinweise)

  • BosentanCYP3A4-InduktorGeringfügig

    Patients required intervention with a diuretic, fluid management, or hospitalization for decompensating heart failure. (Fachinformation zu Bosentan, Warnhinweise und Vorsichtsmaßnahmen)

  • CalciumgluconatGeringfügig

    Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (Fachinformation zu Calciumgluconat, Arzneimittelwechselwirkungen)

  • CorticotropinGeringfügig

    Acthar Gel may accentuate the electrolyte loss associated with diuretic therapy. (Fachinformation zu Corticotropin, Arzneimittelwechselwirkungen)

  • DasatinibGeringfügig

    Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (Fachinformation zu Dasatinib, Warnhinweise und Vorsichtsmaßnahmen)

  • DocetaxelGeringfügig

    Patients developing peripheral edema may be treated with standard measures, e.g., salt restriction, oral diuretic(s). (Fachinformation zu Docetaxel, Warnhinweise und Vorsichtsmaßnahmen)

  • DronedaronAntiarrhythmikumGeringfügig

    Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics Hypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. (Fachinformation zu Dronedaron, Warnhinweise und Vorsichtsmaßnahmen)

  • Finasterid5-Alpha-ReduktasehemmerGeringfügig

    …clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives… (Fachinformation zu Finasterid, Arzneimittelwechselwirkungen)

  • FlecainidAntiarrhythmikumGeringfügig

    Flecainide acetate has been used in a large number of patients receiving diuretics without apparent interaction. (Fachinformation zu Flecainid, Arzneimittelwechselwirkungen)

  • ImatinibCYP3A4-HemmerGeringfügig

    Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. (Fachinformation zu Imatinib, Warnhinweise und Vorsichtsmaßnahmen)

  • MacitentanGeringfügig

    Postmarketing cases of edema and fluid retention occurring within weeks of starting OPSUMIT, some requiring intervention with a diuretic or hospitalization for decompensated heart failure, have been reported [see Adverse Reactions (6.2) ] . (Fachinformation zu Macitentan, Warnhinweise und Vorsichtsmaßnahmen)

  • MemantinGeringfügig

    Urine pH is altered by diet, drugs (e.g. carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g. renal tubular acidosis or severe infections of the urinary tract). (Fachinformation zu Memantin, Arzneimittelwechselwirkungen)

  • Memantin und DonepezilCholinesterasehemmerGeringfügig

    Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract). (Fachinformation zu Memantin und Donepezil, Arzneimittelwechselwirkungen)

  • MethenaminAntibiotikumGeringfügig

    Acetazolamide may prevent the urinary antiseptic effect of methenamine. (Fachinformation zu Acetazolamid, Arzneimittelwechselwirkungen)

  • MethylprednisolonKortikosteroidGeringfügig

    Amphotericin B injection and potassium-depleting agents : When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. (Fachinformation zu Methylprednisolon, Arzneimittelwechselwirkungen)

  • MethyltestosteronAndrogenGeringfügig

    In addition to discontinuation of the drug, diuretic therapy may be required. (Fachinformation zu Methyltestosteron, Warnhinweise)

  • Lack of Effectiveness Methemoglobinemia may not resolve or may rebound after response to treatment with PROVAYBLUE in patients with methemoglobinemia due to aryl amines such as aniline or sulfa drugs such as dapsone. (Fachinformation zu Methylthioniniumchlorid (Methylenblau), Warnhinweise und Vorsichtsmaßnahmen)

  • PentoxifyllinMethylxanthinGeringfügig

    Pentoxifylline extended-release tablets have been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, and antiarrhythmics, without observed problems. (Fachinformation zu Pentoxifyllin, Arzneimittelwechselwirkungen)

  • Piperacillin und TazobactamPenicillin-AntibiotikumGeringfügig

    Periodic electrolyte determinations should be performed in patients with low potassium reserves, and the possibility of hypokalemia should be kept in mind with patients who have potentially low potassium reserves and who are receiving cytotoxic therapy or diuretics. (Fachinformation zu Piperacillin und Tazobactam, Warnhinweise und Vorsichtsmaßnahmen)

  • PrednisolonKortikosteroidGeringfügig

    Potassium-depleting agents (e.g., diuretics, Amphotericin B): When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (Fachinformation zu Prednisolon, Arzneimittelwechselwirkungen)

  • PrednisonKortikosteroidGeringfügig

    Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (Fachinformation zu Prednison, Arzneimittelwechselwirkungen)

  • SulfadiazinSulfonamidGeringfügig

    Potentiation of the action of sulfonylurea hypoglycemic agents, thiazide diuretics and uricosuric agents may also be noted. (Fachinformation zu Sulfadiazin, Arzneimittelwechselwirkungen)

  • Sulfadiazin-SilberSulfonamidGeringfügig

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (Fachinformation zu Sulfadiazin-Silber, Warnhinweise und Vorsichtsmaßnahmen)

  • TerbinafinAntimykotikumGeringfügig

    There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers. (Fachinformation zu Terbinafin, Arzneimittelwechselwirkungen)

  • TriamcinolonKortikosteroidGeringfügig

    Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents ( i.e., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. (Fachinformation zu Triamcinolon, Arzneimittelwechselwirkungen)

  • In addition to discontinuation of the drug, diuretic therapy may be required. (Fachinformation zu Veresterte Estrogene und Methyltestosteron, Warnhinweise)

Keine relevante Wechselwirkung berichtet (3)

  • BisoprololBetablockerKeine Wechselwirkung

    Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including thiazide diuretics and cimetidine. (Fachinformation zu Bisoprolol, Arzneimittelwechselwirkungen)

  • MexiletinAntiarrhythmikumKeine Wechselwirkung

    ECG intervals (PR, QRS, and QT) were not affected by concurrent mexiletine and digoxin, diuretics, or propranolol. (Fachinformation zu Mexiletin, Arzneimittelwechselwirkungen)

  • PamidronsäureBisphosphonatKeine Wechselwirkung

    Loop Diuretics Concomitant administration of a loop diuretic had no effect on the calcium-lowering action of pamidronate disodium. (Fachinformation zu Pamidronsäure, Arzneimittelwechselwirkungen)

Prüfen Sie Acetazolamid gegen alles, was Sie einnehmen. Fügen Sie Ihre gesamte Liste hinzu; alle Paare werden auf einmal geprüft.

Im Wechselwirkungscheck öffnen

Keine medizinische Beratung. Der Schweregrad gibt die Formulierung der Fachinformation wieder, nicht Ihre persönlichen Umstände. Eine als „schwerwiegend“ eingestufte Wechselwirkung kann unter Aufsicht Routine sein, und eine „geringfügige“ kann bei hohen Dosen von Bedeutung sein. Fragen Sie in einer Apotheke nach.